The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Open accessAbstract
Hairy cell leukemia is an uncommon hematologic malignancy characterized by pancytopenia and marked susceptibility to infection. Tremendous progress in the management of patients with this disease has resulted in high response rates and improved survival, yet relapse and an appropriate approach to re-treatment present continuing areas for research. The disease and its effective treatment are associated with immunosuppression. Because more patients are being treated with alternative programs, comparison of results will require general agreement on definitions of response, relapse, and methods of determining minimal residual disease. The development of internationally accepted, reproducible criteria is of paramount importance in evaluating and comparing clinical trials to provide optimal care. Despite the success achieved in managing these patients, continued participation in available clinical trials in the first-line and particularly in the relapse setting is highly recommended. The Hairy Cell Leukemia Foundation convened an international conference to provide common definitions and structure to guide current management. There is substantial opportunity for continued research in this disease. In addition to the importance of optimizing the prevention and management of the serious risk of infection, organized evaluations of minimal residual disease and treatment at relapse offer ample opportunities for clinical research. Finally, a scholarly evaluation of quality of life in the increasing number of survivors of this now manageable chronic illness merits further study. The development of consensus guidelines for this disease offers a framework for continued enhancement of the outcome for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
BRAF Mutations in Hairy-Cell Leukemia
Tiacci, E., Trifonov, V., Schiavoni, G., Holmes, A., Kern, W., Martelli, M. P., Pucciarini, A., Bigerna, B., Pacini, R., Wells, V. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014209 · Cited by 1,024
Self-citationByrd, J. C., Furman, R. R., Coutre, S. E., Burger, J. A., Blum, K. A., Coleman, M., Wierda, W. G., Jones, J. A., Zhao, W., Heerema, N. A., et al. (2015) · Blood · doi:10.1182/blood-2014-10-606038 · Cited by 663
Self-citationLeukemic Reticuloendotheliosis
BOURONCLE, B. A., WISEMAN, B. K., & DOAN, C. A. (1958) · Blood · doi:10.1182/blood.v13.7.609.609 · Cited by 569
Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine
Piro, L. D., Carrera, C. J., Carson, D. A., & Beutler, E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221605 · Cited by 505
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
Tiacci, E., Park, J. H., De Carolis, L., Chung, S. S., Broccoli, A., Scott, S., Zaja, F., Devlin, S., Pulsoni, A., Chung, Y. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506583 · Cited by 348
Self-citationKreitman, R. J., Tallman, M. S., Robak, T., Coutre, S., Wilson, W. H., Stetler-Stevenson, M., FitzGerald, D. J., Lechleider, R., & Pastan, I. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.1756 · Cited by 295
Self-citationHigh prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias
Waterfall, J. J., Arons, E., Walker, R. L., Pineda, M., Roth, L., Killian, J. K., Abaan, O. D., Davis, S. R., Kreitman, R. J., & Meltzer, P. S. (2014) · Nature Genetics · doi:10.1038/ng.2828 · Cited by 276
Self-citationBRAF Inhibition in Refractory Hairy-Cell Leukemia
Dietrich, S., Glimm, H., Andrulis, M., von Kalle, C., Ho, A. D., & Zenz, T. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1202124 · Cited by 255
Self-citationFalini, B., Tiacci, E., Liso, A., Basso, K., Sabattini, E., Pacini, R., Foa, R., Pulsoni, A., Favera, R. D., & Pileri, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16356-3 · Cited by 244
Self-citation
Cited by
Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
Pierpont, T. M., Limper, C. B., & Richards, K. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00163 · Cited by 374
Metadata
- Authors
- Grever, M. R., Abdel-Wahab, O., Andritsos, L. A., Banerji, V., Barrientos, J., Blachly, J. S., Call, T. G., Catovsky, D., Dearden, C., Demeter, J., Else, M., Forconi, F., Gozzetti, A., Ho, A. D., Johnston, J. B., Jones, J., Juliusson, G., Kraut, E., Kreitman, R. J., Larratt, L., Lauria, F., Lozanski, G., Montserrat, E., Parikh, S. A., Park, J. H., Polliack, A., Quest, G. R., Rai, K. R., Ravandi, F., Robak, T., Saven, A., Seymour, J. F., Tadmor, T., Tallman, M. S., Tam, C., Tiacci, E., Troussard, X., Zent, C. S., Zenz, T., Zinzani, P. L., & Falini, B.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-02-02
- Volume
- 129
- Issue
- 5
- Pages
- 553-560
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2558871324
- Cited by
- 289
- References
- 30
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. https://app.cochat.ai/papers/10.1182/blood-2016-01-689422
- The paper
- Grever, M. R., Abdel-Wahab, O., Andritsos, L. A., Banerji, V., Barrientos, J., Blachly, J. S., Call, T. G., Catovsky, D., Dearden, C., Demeter, J., Else, M., Forconi, F., Gozzetti, A., Ho, A. D., Johnston, J. B., Jones, J., Juliusson, G., Kraut, E., Kreitman, R. J., . . . Falini, B. (2017). Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. https://doi.org/10.1182/blood-2016-01-689422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.